143 related articles for article (PubMed ID: 25256183)
1. Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke.
Jusufovic M; Sandset EC; Bath PM; Berge E;
Stroke; 2014 Nov; 45(11):3440-2. PubMed ID: 25256183
[TBL] [Abstract][Full Text] [Related]
2. Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST).
Hornslien AG; Sandset EC; Igland J; Terént A; Boysen G; Bath PM; Murray GD; Berge E
Int J Stroke; 2015 Aug; 10(6):830-5. PubMed ID: 25808741
[TBL] [Abstract][Full Text] [Related]
3. Effects of blood pressure-lowering treatment in different subtypes of acute ischemic stroke.
Sandset EC; Jusufovic M; Sandset PM; Bath PM; Berge E;
Stroke; 2015 Mar; 46(3):877-9. PubMed ID: 25657183
[TBL] [Abstract][Full Text] [Related]
4. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.
Sandset EC; Bath PM; Boysen G; Jatuzis D; Kõrv J; Lüders S; Murray GD; Richter PS; Roine RO; Terént A; Thijs V; Berge E;
Lancet; 2011 Feb; 377(9767):741-50. PubMed ID: 21316752
[TBL] [Abstract][Full Text] [Related]
5. Effects of blood pressure lowering in patients with acute ischemic stroke and carotid artery stenosis.
Jusufovic M; Sandset EC; Bath PM; Karlson BW; Berge E;
Int J Stroke; 2015 Apr; 10(3):354-9. PubMed ID: 25472578
[TBL] [Abstract][Full Text] [Related]
6. Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage.
Jusufovic M; Berge TE; Guo R; You S; Delcourt C; Anderson C; Bath PM; Karlson BW; Berge E; Sandset EC;
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2262-2267. PubMed ID: 31178359
[TBL] [Abstract][Full Text] [Related]
7. Effects of candesartan in acute stroke on cognitive function and quality of life: results from the Scandinavian Candesartan Acute Stroke Trial.
Hornslien AG; Sandset EC; Bath PM; Wyller TB; Berge E;
Stroke; 2013 Jul; 44(7):2022-4. PubMed ID: 23660849
[TBL] [Abstract][Full Text] [Related]
8. Effects of candesartan in acute stroke on activities of daily living and level of care at 6 months.
Hornslien AG; Sandset EC; Wyller TB; Berge E;
J Hypertens; 2015 Jul; 33(7):1487-91. PubMed ID: 26039534
[TBL] [Abstract][Full Text] [Related]
9. Early blood pressure lowering treatment in acute stroke. Ordinal analysis of vascular events in the Scandinavian Candesartan Acute Stroke Trial (SCAST).
Jusufovic M; Sandset EC; Bath PM; Berge E;
J Hypertens; 2016 Aug; 34(8):1594-8. PubMed ID: 27228435
[TBL] [Abstract][Full Text] [Related]
10. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
[TBL] [Abstract][Full Text] [Related]
11. Response to letter regarding article, "Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke".
Jusufovic M; Sandset EC; Berge E;
Stroke; 2015 Jan; 46(1):e14. PubMed ID: 25492909
[No Abstract] [Full Text] [Related]
12. Letter by Gioia et al regarding article, "Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke".
Gioia LC; Kate M; Butcher K
Stroke; 2015 Jan; 46(1):e13. PubMed ID: 25492907
[No Abstract] [Full Text] [Related]
13. Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome.
Sandset EC; Murray GD; Bath PM; Kjeldsen SE; Berge E;
Stroke; 2012 Aug; 43(8):2108-14. PubMed ID: 22627991
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003).
Sandset EC; Murray G; Boysen G; Jatuzis D; Kõrv J; Lüders S; Richter PS; Roine RO; Terént A; Thijs V; Berge E;
Int J Stroke; 2010 Oct; 5(5):423-7. PubMed ID: 20854630
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
[TBL] [Abstract][Full Text] [Related]
16. Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies.
Wei F; Jia XJ; Yu SQ; Gu Y; Wang L; Guo XM; Wang M; Zhu F; Cheng X; Wei YM; Zhou ZH; Fu M; Liao YH;
Heart; 2011 Mar; 97(6):479-84. PubMed ID: 21296780
[TBL] [Abstract][Full Text] [Related]
17. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors.
Schrader J; Lüders S; Kulschewski A; Berger J; Zidek W; Treib J; Einhäupl K; Diener HC; Dominiak P;
Stroke; 2003 Jul; 34(7):1699-703. PubMed ID: 12817109
[TBL] [Abstract][Full Text] [Related]
18. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
London G; Schmieder R; Calvo C; Asmar R
Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
[TBL] [Abstract][Full Text] [Related]
19. Candesartan cilexetil in the management of blood pressure for acute and recurrent stroke in Japan: the Challenge-Stroke study.
Tanahashi N; Nakagawara J; Okada Y; Minematsu K;
Expert Rev Cardiovasc Ther; 2011 Sep; 9(9):1115-26. PubMed ID: 21932954
[TBL] [Abstract][Full Text] [Related]
20. Candesartan for the prevention and treatment of stroke - results of the SCOPE and ACCESS trials.
Doggrell SA;
Expert Opin Pharmacother; 2004 Mar; 5(3):687-90. PubMed ID: 15013936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
